nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—SLC28A3—respiratory system—chronic obstructive pulmonary disease	0.0279	0.141	CbGeAlD
Fludarabine—SLC28A3—trachea—chronic obstructive pulmonary disease	0.0206	0.104	CbGeAlD
Fludarabine—RRM1—respiratory system—chronic obstructive pulmonary disease	0.0156	0.0784	CbGeAlD
Fludarabine—SLC28A3—lung—chronic obstructive pulmonary disease	0.0148	0.0746	CbGeAlD
Fludarabine—RRM1—bronchus—chronic obstructive pulmonary disease	0.0128	0.0645	CbGeAlD
Fludarabine—SLC29A1—respiratory system—chronic obstructive pulmonary disease	0.0127	0.0637	CbGeAlD
Fludarabine—RRM1—smooth muscle tissue—chronic obstructive pulmonary disease	0.0125	0.0631	CbGeAlD
Fludarabine—SLC29A1—connective tissue—chronic obstructive pulmonary disease	0.0111	0.0561	CbGeAlD
Fludarabine—SLC29A1—bronchus—chronic obstructive pulmonary disease	0.0104	0.0525	CbGeAlD
Fludarabine—POLA1—lung—chronic obstructive pulmonary disease	0.0104	0.0524	CbGeAlD
Fludarabine—DCK—bronchus—chronic obstructive pulmonary disease	0.00996	0.0501	CbGeAlD
Fludarabine—SLC29A1—trachea—chronic obstructive pulmonary disease	0.00936	0.0471	CbGeAlD
Fludarabine—DCK—trachea—chronic obstructive pulmonary disease	0.00894	0.045	CbGeAlD
Fludarabine—RRM1—lung—chronic obstructive pulmonary disease	0.00827	0.0416	CbGeAlD
Fludarabine—SLC29A1—lung—chronic obstructive pulmonary disease	0.00673	0.0338	CbGeAlD
Fludarabine—DCK—lung—chronic obstructive pulmonary disease	0.00643	0.0323	CbGeAlD
Fludarabine—DCK—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00305	0.257	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00298	0.251	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00296	0.249	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00289	0.243	CbGdCrCtD
Fludarabine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.0024	0.00305	CcSEcCtD
Fludarabine—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.00304	CcSEcCtD
Fludarabine—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00238	0.00301	CcSEcCtD
Fludarabine—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00238	0.00301	CcSEcCtD
Fludarabine—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00237	0.00301	CcSEcCtD
Fludarabine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00237	0.00301	CcSEcCtD
Fludarabine—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00236	0.00299	CcSEcCtD
Fludarabine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00233	0.00296	CcSEcCtD
Fludarabine—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00233	0.00295	CcSEcCtD
Fludarabine—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00231	0.00292	CcSEcCtD
Fludarabine—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00231	0.00292	CcSEcCtD
Fludarabine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00229	0.0029	CcSEcCtD
Fludarabine—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00288	CcSEcCtD
Fludarabine—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00226	0.00286	CcSEcCtD
Fludarabine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00225	0.00285	CcSEcCtD
Fludarabine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.00285	CcSEcCtD
Fludarabine—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.00284	CcSEcCtD
Fludarabine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00223	0.00283	CcSEcCtD
Fludarabine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00222	0.00281	CcSEcCtD
Fludarabine—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00222	0.00281	CcSEcCtD
Fludarabine—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.0022	0.00278	CcSEcCtD
Fludarabine—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.0022	0.00278	CcSEcCtD
Fludarabine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00219	0.00278	CcSEcCtD
Fludarabine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.00271	CcSEcCtD
Fludarabine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00214	0.00271	CcSEcCtD
Fludarabine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00213	0.0027	CcSEcCtD
Fludarabine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00213	0.0027	CcSEcCtD
Fludarabine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00211	0.00268	CcSEcCtD
Fludarabine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00211	0.00267	CcSEcCtD
Fludarabine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00211	0.00267	CcSEcCtD
Fludarabine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0021	0.00266	CcSEcCtD
Fludarabine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00209	0.00265	CcSEcCtD
Fludarabine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00208	0.00264	CcSEcCtD
Fludarabine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00208	0.00264	CcSEcCtD
Fludarabine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00207	0.00262	CcSEcCtD
Fludarabine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00207	0.00262	CcSEcCtD
Fludarabine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00203	0.00257	CcSEcCtD
Fludarabine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00256	CcSEcCtD
Fludarabine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00199	0.00252	CcSEcCtD
Fludarabine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00198	0.00251	CcSEcCtD
Fludarabine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00197	0.00249	CcSEcCtD
Fludarabine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00197	0.00249	CcSEcCtD
Fludarabine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00194	0.00246	CcSEcCtD
Fludarabine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00245	CcSEcCtD
Fludarabine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00245	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00192	0.00243	CcSEcCtD
Fludarabine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00243	CcSEcCtD
Fludarabine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00243	CcSEcCtD
Fludarabine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00189	0.0024	CcSEcCtD
Fludarabine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00188	0.00238	CcSEcCtD
Fludarabine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00188	0.00238	CcSEcCtD
Fludarabine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00188	0.00238	CcSEcCtD
Fludarabine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00185	0.00235	CcSEcCtD
Fludarabine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00183	0.00231	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00182	0.0023	CcSEcCtD
Fludarabine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00182	0.0023	CcSEcCtD
Fludarabine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00182	0.0023	CcSEcCtD
Fludarabine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00181	0.00229	CcSEcCtD
Fludarabine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.0018	0.00228	CcSEcCtD
Fludarabine—Cough—Montelukast—chronic obstructive pulmonary disease	0.00178	0.00226	CcSEcCtD
Fludarabine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00177	0.00225	CcSEcCtD
Fludarabine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00225	CcSEcCtD
Fludarabine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00225	CcSEcCtD
Fludarabine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00225	CcSEcCtD
Fludarabine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00225	CcSEcCtD
Fludarabine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00224	CcSEcCtD
Fludarabine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00224	CcSEcCtD
Fludarabine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00175	0.00222	CcSEcCtD
Fludarabine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.00222	CcSEcCtD
Fludarabine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00174	0.0022	CcSEcCtD
Fludarabine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00174	0.0022	CcSEcCtD
Fludarabine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.00218	CcSEcCtD
Fludarabine—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00171	0.00217	CcSEcCtD
Fludarabine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.0017	0.00215	CcSEcCtD
Fludarabine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.0017	0.00215	CcSEcCtD
Fludarabine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.0017	0.00215	CcSEcCtD
Fludarabine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.0017	0.00215	CcSEcCtD
Fludarabine—Infection—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00214	CcSEcCtD
Fludarabine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00214	CcSEcCtD
Fludarabine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00212	CcSEcCtD
Fludarabine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00212	CcSEcCtD
Fludarabine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00167	0.00211	CcSEcCtD
Fludarabine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00167	0.00211	CcSEcCtD
Fludarabine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00211	CcSEcCtD
Fludarabine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00211	CcSEcCtD
Fludarabine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.0021	CcSEcCtD
Fludarabine—Infection—Montelukast—chronic obstructive pulmonary disease	0.00165	0.0021	CcSEcCtD
Fludarabine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00165	0.00209	CcSEcCtD
Fludarabine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00207	CcSEcCtD
Fludarabine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00207	CcSEcCtD
Fludarabine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00203	CcSEcCtD
Fludarabine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00203	CcSEcCtD
Fludarabine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00202	CcSEcCtD
Fludarabine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.002	CcSEcCtD
Fludarabine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00158	0.002	CcSEcCtD
Fludarabine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00199	CcSEcCtD
Fludarabine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00155	0.00197	CcSEcCtD
Fludarabine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00197	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00196	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00196	CcSEcCtD
Fludarabine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00194	CcSEcCtD
Fludarabine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00153	0.00194	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00192	CcSEcCtD
Fludarabine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00192	CcSEcCtD
Fludarabine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00192	CcSEcCtD
Fludarabine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.0015	0.0019	CcSEcCtD
Fludarabine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.0015	0.0019	CcSEcCtD
Fludarabine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.0019	CcSEcCtD
Fludarabine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0015	0.00189	CcSEcCtD
Fludarabine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00149	0.00189	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00186	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00186	CcSEcCtD
Fludarabine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00186	CcSEcCtD
Fludarabine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00186	CcSEcCtD
Fludarabine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00186	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00185	CcSEcCtD
Fludarabine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00184	CcSEcCtD
Fludarabine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00184	CcSEcCtD
Fludarabine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00184	CcSEcCtD
Fludarabine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00184	CcSEcCtD
Fludarabine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00183	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00144	0.00182	CcSEcCtD
Fludarabine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00144	0.00182	CcSEcCtD
Fludarabine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00181	CcSEcCtD
Fludarabine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00142	0.0018	CcSEcCtD
Fludarabine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00142	0.0018	CcSEcCtD
Fludarabine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.0018	CcSEcCtD
Fludarabine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00142	0.00179	CcSEcCtD
Fludarabine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00142	0.00179	CcSEcCtD
Fludarabine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00179	CcSEcCtD
Fludarabine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00178	CcSEcCtD
Fludarabine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00178	CcSEcCtD
Fludarabine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00178	CcSEcCtD
Fludarabine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00178	CcSEcCtD
Fludarabine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00177	CcSEcCtD
Fludarabine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00177	CcSEcCtD
Fludarabine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.0014	0.00177	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00176	CcSEcCtD
Fludarabine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00175	CcSEcCtD
Fludarabine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00174	CcSEcCtD
Fludarabine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00174	CcSEcCtD
Fludarabine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00173	CcSEcCtD
Fludarabine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00134	0.0017	CcSEcCtD
Fludarabine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.0017	CcSEcCtD
Fludarabine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.0017	CcSEcCtD
Fludarabine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00168	CcSEcCtD
Fludarabine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00168	CcSEcCtD
Fludarabine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.00168	CcSEcCtD
Fludarabine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00168	CcSEcCtD
Fludarabine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00167	CcSEcCtD
Fludarabine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00167	CcSEcCtD
Fludarabine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.00165	CcSEcCtD
Fludarabine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.00164	CcSEcCtD
Fludarabine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00161	CcSEcCtD
Fludarabine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00159	CcSEcCtD
Fludarabine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00159	CcSEcCtD
Fludarabine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00159	CcSEcCtD
Fludarabine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00125	0.00158	CcSEcCtD
Fludarabine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00155	CcSEcCtD
Fludarabine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00155	CcSEcCtD
Fludarabine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00155	CcSEcCtD
Fludarabine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00152	CcSEcCtD
Fludarabine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00152	CcSEcCtD
Fludarabine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00151	CcSEcCtD
Fludarabine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.0015	CcSEcCtD
Fludarabine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00149	CcSEcCtD
Fludarabine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00147	CcSEcCtD
Fludarabine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00147	CcSEcCtD
Fludarabine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.00147	CcSEcCtD
Fludarabine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00146	CcSEcCtD
Fludarabine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00145	CcSEcCtD
Fludarabine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00144	CcSEcCtD
Fludarabine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00144	CcSEcCtD
Fludarabine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00139	CcSEcCtD
Fludarabine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00139	CcSEcCtD
Fludarabine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00137	CcSEcCtD
Fludarabine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00137	CcSEcCtD
Fludarabine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00136	CcSEcCtD
Fludarabine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00136	CcSEcCtD
Fludarabine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00136	CcSEcCtD
Fludarabine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00136	CcSEcCtD
Fludarabine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00135	CcSEcCtD
Fludarabine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00135	CcSEcCtD
Fludarabine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00134	CcSEcCtD
Fludarabine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00134	CcSEcCtD
Fludarabine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00133	CcSEcCtD
Fludarabine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00133	CcSEcCtD
Fludarabine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00105	0.00133	CcSEcCtD
Fludarabine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00132	CcSEcCtD
Fludarabine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00131	CcSEcCtD
Fludarabine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00103	0.0013	CcSEcCtD
Fludarabine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00103	0.0013	CcSEcCtD
Fludarabine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00129	CcSEcCtD
Fludarabine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00102	0.00129	CcSEcCtD
Fludarabine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00128	CcSEcCtD
Fludarabine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00128	CcSEcCtD
Fludarabine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00128	CcSEcCtD
Fludarabine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00128	CcSEcCtD
Fludarabine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00127	CcSEcCtD
Fludarabine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000989	0.00125	CcSEcCtD
Fludarabine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000978	0.00124	CcSEcCtD
Fludarabine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000954	0.00121	CcSEcCtD
Fludarabine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000949	0.0012	CcSEcCtD
Fludarabine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000947	0.0012	CcSEcCtD
Fludarabine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000942	0.00119	CcSEcCtD
Fludarabine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000921	0.00117	CcSEcCtD
Fludarabine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000921	0.00117	CcSEcCtD
Fludarabine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00089	0.00113	CcSEcCtD
Fludarabine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000842	0.00107	CcSEcCtD
Fludarabine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000832	0.00105	CcSEcCtD
Fludarabine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000827	0.00105	CcSEcCtD
Fludarabine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00082	0.00104	CcSEcCtD
Fludarabine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000788	0.000998	CcSEcCtD
Fludarabine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000761	0.000964	CcSEcCtD
Fludarabine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000759	0.000961	CcSEcCtD
Fludarabine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000758	0.00096	CcSEcCtD
Fludarabine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000754	0.000955	CcSEcCtD
Fludarabine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00074	0.000937	CcSEcCtD
Fludarabine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000711	0.0009	CcSEcCtD
Fludarabine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000698	0.000884	CcSEcCtD
Fludarabine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000698	0.000884	CcSEcCtD
Fludarabine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00069	0.000874	CcSEcCtD
Fludarabine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000679	0.00086	CcSEcCtD
Fludarabine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000669	0.000848	CcSEcCtD
Fludarabine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000669	0.000848	CcSEcCtD
Fludarabine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000665	0.000842	CcSEcCtD
Fludarabine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000656	0.000831	CcSEcCtD
Fludarabine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000647	0.00082	CcSEcCtD
Fludarabine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000638	0.000808	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00061	0.000772	CcSEcCtD
Fludarabine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000601	0.000761	CcSEcCtD
Fludarabine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000589	0.000746	CcSEcCtD
Fludarabine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000582	0.000737	CcSEcCtD
Fludarabine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000581	0.000736	CcSEcCtD
Fludarabine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00058	0.000735	CcSEcCtD
Fludarabine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000577	0.000731	CcSEcCtD
Fludarabine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000577	0.000731	CcSEcCtD
Fludarabine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000572	0.000725	CcSEcCtD
Fludarabine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000552	0.000699	CcSEcCtD
Fludarabine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000547	0.000693	CcSEcCtD
Fludarabine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000529	0.00067	CcSEcCtD
Fludarabine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000493	0.000625	CcSEcCtD
Fludarabine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00048	0.000608	CcSEcCtD
Fludarabine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000474	0.0006	CcSEcCtD
Fludarabine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000458	0.00058	CcSEcCtD
Fludarabine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000426	0.000539	CcSEcCtD
Fludarabine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000422	0.000535	CcSEcCtD
Fludarabine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000422	0.000534	CcSEcCtD
Fludarabine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000419	0.000531	CcSEcCtD
Fludarabine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000398	0.000504	CcSEcCtD
